Dual-immunotherapy and short-course medium-dose radiotherapy, followed by surgery for tumor microenvironment modification in early stage NSCLC: The DIRECT-trial

Autor: Dickhoff, C., Senan, S., Schneiders, F. L., Veltman, J., Hashemi, S., Fransen, M., Heineman, D., Radonic, T., van de Ven, P., Bartelink, I. H., Meijboom, L., Oprea-Lager, D., Garcia-Vallejo, J., Bouwhuis, N., de Gruijl, T. D., Bahce, I.
Přispěvatelé: Cardio-thoracic surgery, Surgery, CCA - Cancer Treatment and quality of life, Radiation Oncology, AII - Cancer immunology, Pulmonary medicine, Pathology, Epidemiology and Data Science, Clinical pharmacology and pharmacy, Radiology and nuclear medicine, Molecular cell biology and Immunology, Medical oncology laboratory
Jazyk: angličtina
Rok vydání: 2021
Zdroj: Annals of Oncology, 32, S1427-S1427. Oxford University Press
Dickhoff, C, Senan, S, Schneiders, F L, Veltman, J, Hashemi, S, Fransen, M, Heineman, D, Radonic, T, van de Ven, P, Bartelink, I H, Meijboom, L, Oprea-Lager, D, Garcia-Vallejo, J, Bouwhuis, N, de Gruijl, T D & Bahce, I 2021, ' Dual-immunotherapy and short-course medium-dose radiotherapy, followed by surgery for tumor microenvironment modification in early stage NSCLC: The DIRECT-trial ', Annals of Oncology, vol. 32, pp. S1427-S1427 . https://doi.org/10.1016/j.annonc.2021.10.137
ISSN: 0923-7534
DOI: 10.1016/j.annonc.2021.10.137
Databáze: OpenAIRE